Affimed (AFMD)
(Delayed Data from NSDQ)
$3.69 USD
-0.27 (-6.82%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $3.70 +0.01 (0.27%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth B Momentum F VGM
Affimed N.V. (AFMD) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$15.17 | $25.00 | $5.00 | 283.08% |
Price Target
Based on short-term price targets offered by six analysts, the average price target for Affimed N.V. comes to $15.17. The forecasts range from a low of $5.00 to a high of $25.00. The average price target represents an increase of 283.08% from the last closing price of $3.96.
Analyst Price Targets (6 )
Broker Rating
Affimed N.V. currently has an average brokerage recommendation (ABR) of 1.29 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by seven brokerage firms. The current ABR compares to an ABR of 1.29 a month ago based on seven recommendations.
Of the seven recommendations deriving the current ABR, six are Strong Buy, representing 85.71% of all recommendations. A month ago, Strong Buy represented 85.71%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 6 | 6 | 6 | 6 | 6 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 1 | 1 | 1 | 1 | 1 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.29 | 1.29 | 1.29 | 1.29 | 1.29 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
9/17/2024 | Truist Securities | Srikripa Devarakonda | Strong Buy | Strong Buy |
9/11/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
9/9/2024 | Cantor Fitzgerald & Co | Li Watsek | Strong Buy | Strong Buy |
9/6/2024 | H.C. Wainwright & Co. | Swayampakula Ramakanth | Strong Buy | Strong Buy |
6/12/2024 | Not Identified | Not Identified | Hold | Hold |
5/15/2024 | SVB Securities | Daina M Graybosch | Strong Buy | Strong Buy |
4/1/2024 | Wells Fargo Securities | Yanan Zhu | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.29 |
ABR (Last week) | 1.29 |
# of Recs in ABR | 7 |
Average Target Price | $15.17 |
LT Growth Rate | NA |
Industry | Medical - Biomedical and Genetics |
Industry Rank by ABR | 79 of 253 |
Current Quarter EPS Est: | -0.91 |
AFMD FAQs
Affimed N.V. (AFMD) currently has an average brokerage recommendation (ABR) of 1.29 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 7 brokerage firms.
The average price target for Affimed N.V. (AFMD) is $15.17. The current on short-term price targets is based on 5 reports.
The forecasts for Affimed N.V. (AFMD) range from a low of $5 to a high of $25. The average price target represents a increase of $311.11 from the last closing price of $3.69.
The current UPSIDE for Affimed N.V. (AFMD) is 311.11%
Based on short-term price targets offered by six analysts, the average price target for Affimed N.V. comes to $15.17. The forecasts range from a low of $5.00 to a high of $25.00. The average price target represents an increase of 283.08% from the last closing price of $3.96.